ChromaDex to Present at the 5th Annual B. Riley FBR Consumer and Media Conference
September 26 2019 - 6:30AM
ChromaDex Corp. (NASDAQ:CDXC) announced today that its Chief
Executive Officer, Rob Fried, and Chief Financial
Officer, Kevin Farr, will present at the
5th Annual B. Riley FBR Consumer and Media
Conference at the Sofitel Hotel in New York, NY.
The ChromaDex management team is scheduled to present
on Thursday, October 3, 2019 at 2:00 p.m. Eastern Time
(11:00 a.m. Pacific Time). The presentation will be webcast
live via the link below on the investor relations section of the
Company’s website at www.chromadex.com.
Webcast link: ChromaDex Investor Presentation – B. Riley
FBR
ChromaDex management will also attend one-on-one meetings
with institutional investors throughout the day.
About ChromaDex: ChromaDex Corp. is a
science-based integrated nutraceutical company devoted to improving
the way people age. ChromaDex scientists partner with
leading universities and research institutions worldwide to uncover
the full potential of NAD and identify and develop novel,
science-based ingredients. Its flagship
ingredient, NIAGEN® nicotinamide riboside, sold directly
to consumers as TRU NIAGEN®, is backed with clinical and
scientific research, as well as extensive IP protection. TRU
NIAGEN® is helping the world AGE
BETTER®. ChromaDex maintains a website
at www.chromadex.com to
which ChromaDex regularly posts copies of its press
releases as well as additional and financial information about the
Company.
Important Note on Forward Looking
Statements:
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities and Exchange Act of 1934, as
amended. Because such statements are subject to risks and
uncertainties, actual results may differ materially from those
expressed or implied by such forward-looking statements.
Other risks that contribute to the uncertain nature of the
forward-looking statements are reported in our most recent Forms
10-Q and 10-K as filed with the SEC. Readers are cautioned not to
place undue reliance on these forward-looking statements, which
speak only as of the date hereof, and actual results may differ
materially from those suggested by these forward-looking
statements. All forward-looking statements are qualified in their
entirety by this cautionary statement and ChromaDex undertakes no
obligation to revise or update this release to reflect events or
circumstances after the date hereof.
ChromaDex Investor Relations Contact: Brianna
Gerber, Sr. Director of FP&A and Investor Relations
949-419-0288 ext. 127 briannag@chromadex.com
ChromaDex Media Contact: Alex Worsham, Director
of Strategic Partnerships310-388-6706 ext.
689alexw@chromadex.com
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Mar 2024 to Apr 2024
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Apr 2023 to Apr 2024